Advertisement

Topics

Sequenta, Inc. Company Profile

03:40 EDT 25th June 2018 | BioPortfolio

Sequenta, Inc. is a privately held company developing and commercializing molecular diagnostic assays based on a proprietary sequencing approach to the profiling of T and B cell receptor repertoires. The incredible diversity created by these genes is at the heart of a large number of conditions critical to human health and disease.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Sequenta Inc.

Sequenta is a venture-backed biotechnology company dedicated to improving patient care in diseases mediated by immune cells through the discovery and development of novel clinical...

Sequenta, Inc.

Sequenta, Inc. is a privately held company developing and commercializing molecular diagnostic assays based on a proprietary sequencing approach to the profiling of T and B cell r...

More Information about "Sequenta, Inc." on BioPortfolio

We have published hundreds of Sequenta, Inc. news stories on BioPortfolio along with dozens of Sequenta, Inc. Clinical Trials and PubMed Articles about Sequenta, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sequenta, Inc. Companies in our database. You can also find out about relevant Sequenta, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...


Corporate Database Quicklinks



Searches Linking to this Company Record